2016
DOI: 10.1136/jfprhc-2016-101572
|View full text |Cite
|
Sign up to set email alerts
|

Pain and pain relief with intrauterine device insertion

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
2
0

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 5 publications
0
2
0
Order By: Relevance
“…The authors quoting a Cochrane Review3 say that “pharmacological strategies” fail to show “clear evidence that pain is significantly reduced during or after routine IUC placement”. Yet two double-blind randomised studies2 4 were not evaluated, totalling 190 women.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…The authors quoting a Cochrane Review3 say that “pharmacological strategies” fail to show “clear evidence that pain is significantly reduced during or after routine IUC placement”. Yet two double-blind randomised studies2 4 were not evaluated, totalling 190 women.…”
mentioning
confidence: 99%
“…With tolfenamic acid 200 mg three times a day started post-insertion, significantly reduced ( p <0.01) spasmodic pain was reported in the subsequent 24 hours4; and measured by visual analogue scales (VAS), there was significant post-insertion pain reduction at 10 minutes with mefenamic acid 500 mg given 60 minutes pre-insertion 2. Moreover, the “absence of proof” from other good studies cited in the Cochrane Review3 cannot be “proof of absence” of benefit by non-steroidal anti-inflammatory drugs (NSAIDS) for prostaglandin-related pain.…”
mentioning
confidence: 99%